These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20984406)

  • 1. Immunization with the vole bacillus; the protective value of the vole bacillus (Wells) as compared with BCG against tuberculous infection.
    BIRKHAUG K
    Am Rev Tuberc; 1946 May; 53():411-26. PubMed ID: 20984406
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the virulence and protective potency against tuberculous infection of vole bacillus, low-virulent human tubercle bacillus Imamura's strain, and BCG.
    TOSHIMA M
    Sci Rep Res Inst Tohoku Univ Med; 1952 Dec; 4(2):135-49. PubMed ID: 13064629
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNIZATION with the vole bacillus.
    Vet Rec; 1946 Oct; 58(42):463. PubMed ID: 20275315
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination with the vole bacillus (Wells); protective value of percutaneous and intracutaneous vaccination; observations on multiple puncture vaccination on man.
    BIRKHAUG K
    Am Rev Tuberc; 1946 Jul; 54():41-50. PubMed ID: 20995858
    [No Abstract]   [Full Text] [Related]  

  • 5. Vole bacillus vaccination in guinea pigs: comparison of immunization produced by virulent and attenuated strains of vole bacillus.
    SMITH N
    Tubercle; 1962 Jun; 43():161-5. PubMed ID: 13914367
    [No Abstract]   [Full Text] [Related]  

  • 6. The intracutaneous injection of vole tubercle bacilli in tuberculous persons.
    CAMERON C; PURDIE IA
    Tubercle; 1946 Dec; 27(12):195-201. PubMed ID: 20275957
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical experience with BCG and the Vole bacillus in Renfrew-shire.
    FREW HW
    Tubercle; 1954 Nov; 35(11):277-87. PubMed ID: 13217030
    [No Abstract]   [Full Text] [Related]  

  • 8. The persistence of resistance following the disappearance of hypersensitivity in guinea-pigs after vaccination with vole bacillus and BCG.
    WELLS AQ; WYLIE JA
    Br J Exp Pathol; 1952 Aug; 33(4):405-14. PubMed ID: 14954113
    [No Abstract]   [Full Text] [Related]  

  • 9. VACCINATION AGAINST TUBERCULOSIS WITH KILLED TUBERCLE BACILLI.
    SWEDBERG B
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:67-76. PubMed ID: 14164138
    [No Abstract]   [Full Text] [Related]  

  • 10. The hemagglutination reaction to BCG and vole bacillus vaccinations.
    HAWIRKO RZ
    Can J Microbiol; 1954 Aug; 1(1):79-84. PubMed ID: 14352042
    [No Abstract]   [Full Text] [Related]  

  • 11. B.C.G. and vole bacillus vaccines in the prevention of tuberculosis in adolescents.
    Br Med J; 1959 Sep; 2(5149):379-96. PubMed ID: 13856755
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of vaccination with vole bacillus and B.C.G. vaccines.
    FREW HW; DAVIDSON JR; REID JT
    Br Med J; 1955 Jan; 1(4906):133-6. PubMed ID: 13219360
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUBERCULOIMMUNITY INDUCED BY KILLED TUBERCLE BACILLI AND THEIR CONSTITUENTS.
    CROWLE AJ
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:27-34. PubMed ID: 14164134
    [No Abstract]   [Full Text] [Related]  

  • 15. THE IMMUNE RESPONSE TO ANTIGENS OF THE TUBERCLE BACILLUS IN RELATION TO SPECIFIC ACQUIRED IMMUNITY.
    BOYDEN SV
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:19-26. PubMed ID: 14164133
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the potency test of BCG vaccine; studies on the inoculation of tubercle bacilli (or BCG) into the ocular anterior-chamber of rabbits. II. Determination of the protective effect of BCG vaccines by the challenge with virulent human tubercle bacilli into the ocular anterior-chamber of the immunized rabbits.
    SAKAKI K
    Sci Rep Res Inst Tohoku Univ Med; 1956 Jul; 7(1):97-113. PubMed ID: 13432808
    [No Abstract]   [Full Text] [Related]  

  • 18. EXPERIMENTS WITH KOLLED ANTITUBERCULOUS VACCINES DERIVED FROM BCG AND VOLE BACILLUS.
    SIEBENMANN CO
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:35-46. PubMed ID: 14164135
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacillus Calmette Guérin.
    VALENTINE C
    Am Drug; 1947 Feb; 115(2):90. PubMed ID: 20288728
    [No Abstract]   [Full Text] [Related]  

  • 20. B.C.G. AND vole bacillus vaccines in the prevention of tuberculosis in adolescents; first (progress) report to the Medical Research Council by their Tuberculosis Vaccines Clinical Trials Committee.
    Br Med J; 1956 Feb; 1(4964):413-27. PubMed ID: 13284343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.